Academic & industrial partnerships

Our Success Depends on the Partnerships we build

 

 

To implement our scientific strategy, we have formed key academic collaborations with:

  • INRAE (French National Institute for Agricultural Food and Environment Research)
  • ICAN (French Institute of Cardiometabolism and Nutrition)
  • University of Bordeaux (France)
  • University of Cornell (USA)
  • University of Reading (UK)
  • University of Valencia (Spain)
  • IHU Marseille (France)

 

In December 2019, LNC Therapeutics and INRAE signed a research partnership to study the anti-inflammatory properties of the gut microbiome.
Learn more

We established exclusive industrial partnerships with multiple institutions to explore opportunities for our discovery activities.

Bioaster, Biomeostatis, BIOSE, LUINA BIO and QUAY PHARMA support LNC with the characterization and production of our clinical candidates for preclinical development and manufacturing at GMP standards for clinical evaluation.

Want to talk to our CEO ?

Microbiome & us
News
Sep 8, 2020
LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial on Xla1 for the...
> more
Apr 15, 2020
LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent related to...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Publications
Apr 22, 2020
Keystone gut bacteria are the foundation of the whole microbial ecosystem because they provide very specific metabolic...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
now on twitter
LNC Therapeutics

Could microbiome predict the severity of illness among those exposed to the virus? t.co/VukGBbShDa #GutMicrobiome #Covid19

LNC Therapeutics © 2020 - all rights reserved terms and conditions